ACROBiosystems ACROBiosystems Biotinylated Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130)

Supplier:  ACROBiosystems S1NM13L325UG

Antibody;25UG;Human IgG1/kappa;This product is a specific antibody against SARS-CoV-2 Spike RBD. No cross-reactivity is detected with Spike RBD of other coronaviruses, including SARS-CoV, MERS-CoV, HCoV-229E, HCoV-NL63, HCoV-OC43 and HCoV-HKU1.;Biotinylated Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130) is a chimeric monoclonal antibody recombinantly expressed from HEK293 cells, which combines the variable region of a mouse monoclonal antibody with human IgG1 constant domain. The mouse monoclonal antibody was obtained from a mouse immunized with recombinant SARS-CoV-2 S1 protein. This chimeric antibody is purified by Protein A affinity chromatography.; The protein has a calculated MW of 49.1 kDa | 23.5 kDa. The protein migrates as 27 kDa and 55 kDa under reducing (R) condition (SDS-PAGE).;Immobilized Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM122) (Cat. No.S1N-M12A1) at 2 μg/mL, add increasing concentrations of SARS-CoV-2 S protein RBD, His Ta

Catalog No. 50-210-7174